Department of Pharmacy Practice and Science
College of Pharmacy
University of Nebraska Medical Center
986145 Nebraska Medical Center
Omaha, NE 68198-6145
Phone: (402) 559-7162
Fax: (402) 559-5673
Dr. McAdam Marx teaches in the areas of US health care policy, healthcare quality, health technology assessment, and health services research methodologies. She serves as a research mentor to PharmD students and residents, and she has mentored numerous outcomes research graduate students. Dr. McAdam Marx is working with faculty in the Department of Pharmacy Practice and Science to establish a graduate program in Social, Economic, and Administrative Pharmacy.
Dr. McAdam Marx is a pharmacotherapy health services researcher. Her research helps to establish the effectiveness and value of pharmacist-led comprehensive medication management in primary care, as well as the real-world effectiveness and value of diabetes drug therapies. Her goal is to help improve patient outcomes by generating evidence to support decisions related to access and optimal use of medications and clinical pharmacy services.
- Brown K, Fortenberry K, Gren L, Gunning K, McAdam-Marx C. (2017) Achievement of Adequate Glycemic Control in Patients with Type 2 Diabetes and Comorbid Mental Health Conditions Treated in a Primary Care Setting. Diabetes Spectrum, 30(4):277-287
Gurgle HE, Schauerhamer MB, Rodriguez SA, McAdam-Marx C. (2017) Impact of Statin Guidelines on Statin Utilization and Costs in an Employer-Based Primary Care Clinic. Am J Manag Care; 2017; 23(12):e387-e393.
Fritz J, King J, McAdam-Marx C. (2018) Associations Between Early Care Decisions and the Risk for Long-Term Opioid Use in Opioid-Naïve Patients with a New Physician Consult for Low Back Pain and Initiated on Opioid Therapy. Clin Jour Pain. 2018 Jun;34(6):552-558.
Wittbrodt ET, Eudicone JM, Farahbakhshian S, McAdam-Marx C. (2018) Comparison of Low-Dose Liraglutide use Versus Other GLP-1 Receptor Agonists in Patients Without Type 2 Diabetes. Am Jour Manag Care. 2018 Apr;24(8 Suppl):S156-S164
Kim K, Unni S, McAdam-Marx C, Thomas SM, Sterling KL, Olsen C, Johnstone B, Mitchell M, Brixner D. (2018) Treatment Intensification and Its Influence on HbA1c in Patients with Sub-optimally Controlled Type 2 Diabetes after Two Oral Antidiabetic Agents. J Manag Care Spec Pharm. 2019; 25(3): 314-322.
Ruiz-Negrón N, Wander C, McAdam-Marx C, Pesa J, Bailey RA, Bellows BA. (2018). Factors Associated with Diabetes-related Clinical Inertia in a Managed Care Population and its Impact on HbA1c Goal Attainment: A Claims-Based Analysis. J Manag Care Spec Pharm. 2019; 25(3): 304-313.
Kim K, Unni S, Brixner D, Thomas SM, Sterling KL, Olsen C, Sterling KL, Mitchell M, McAdam-Marx C. (2019) Longitudinal Changes in HbA1c following Treatment Intensification after Inadequate Response to Two Oral Antidiabetic Agents in Patients with Type 2 Diabetes. Diab Obes Met. 2019; 21(7): 1725-1733
King J, McAdam-Marx C, McCaleb R, Davis D, Bemberg GB, Johnson JT. (2018) Cost and Utilization Outcomes after Exclusion of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors in a Self-Funded, State Employee, Managed Care Plan. J Manag Care Spec Pharm. 2019; 25(6): 646-651
McAdam-Marx C, Tak C, Petigara T, Jones NW, Yoo M, Briley M, Gunning K, Gren L. (2018) Impact of a Guideline-Based Best Practice Alert on Pneumococcal Immunization Rates in Adults in a Primary Care Setting. BMC Health Services Research. BMC Health Serv Res. 2019; 19(1):474
Litchman M, Allen NA, McAdam-Marx C, Feehan M. Using Projective Exercises to Identify Patient Perspectives of Living with Comorbid Type 2 Diabetes and Asthma. (2019) Chronic Illness. ePub ahead of print. 2019, Sept 7.